Dr Reddys Laboratories (RDY) Other financing activities (2014 - 2026)

Dr Reddys Laboratories' Other financing activities history runs 13 years deep, the most recent figure standing at $18.4 million for Q1 2026.

• In Q1 2026, Other financing activities fell 2.85% year-over-year to $18.4 million; the TTM figure through Mar 2026 stood at $18.4 million (down 2.85% YoY), while the FY2026 annual figure was $19.1 million, down 1.79% from the prior year.
• Other financing activities was $18.4 million for Q1 2026 at Dr Reddys Laboratories, down from $18.8 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $114.4 million in Q2 2024 to a low of -$168.8 million in Q4 2023.
• Historically, Other financing activities has averaged -$21.7 million across 5 years, with a median of $17.9 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Other financing activities slumped 2476.48% in 2023, then jumped 736.64% in 2024.
• A 5-year view of Other financing activities shows it stood at $7.1 million in 2022, then sank by 2476.48% to -$168.8 million in 2023, then surged by 110.59% to $17.9 million in 2024, then grew by 5.0% to $18.8 million in 2025, then retreated by 1.84% to $18.4 million in 2026.
• The last three Other financing activities figures came in at $18.4 million (Q1 2026), $18.8 million (Q3 2025), and -$14.1 million (Q2 2025), per Business Quant data.